Background Up-to-date (UTD) of the human papillomavirus (HPV) vaccine series has been
low despite 2016 recommendations for 2 doses among initiators< 15 years of age and 3 …

The 9-valent human papillomavirus (9-vHPV) vaccine uptake rate among adolescents has
improved over the years; however, little is known about the adherence to the recommended …

Recent guidelines from the American Cancer Society stress HPV vaccination series initiation
at the youngest opportunity, ie, age 9 years. There are limited data on the association …

OBJECTIVE To assess trends in recent human papillomavirus (HPV) vaccination initiation
and factors associated with vaccination among adolescents. METHODS The 2015 to 2020 …

Objective. To examine correlates of vaccine series completion among young adolescent US
girls who initiated the human papillomavirus (HPV) vaccine. Methods. We analyzed National …

Vaccination rates for human papillomavirus (HPV) have remained disappointingly low. It is
critical to identify methods to increase on-time vaccine series completion rates (before 13 or …

Human papillomavirus (HPV) vaccination uptake in the United States remains suboptimal,
and continues to trail that of tetanus, diphtheria, and acellular pertussis (Tdap) vaccination …

Purpose: To examine correlates of HPV vaccination uptake in a nationally representative
sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified …

Objectives When examining vaccination coverage, researchers must make decisions about
how to define outcome measures based on many factors, including the timing of doses …

Objective Human papillomavirus (HPV) vaccine has been recommended for male patients
for the prevention of genital warts and precancerous anal lesions since 2009. Our objective …